UPDATE: Deutsche Bank Reiterates On Amgen On Potential Of New Drugs
November 12, 2014 at 09:17 AM EST
In a report published Wednesday, Deutsche Bank analyst Robyn Karnauskas reiterated a Buy rating on Amgen (NASDAQ: AMGN), and raised the ...
